FLANIGAN'S REPORTS EARNINGS
FLANIGAN'S REPORTS EARNINGS
PR Newswire
FORT LAUDERDALE, Fla., Feb. 14, 2024
FORT LAUDERDALE, Fla., Feb. 14, 2024 /PRNewswire/ -- FLANIGAN'S ENTERPRISES, INC., (NYSE AMERICAN: BDL) owners and operators of the "Flanigan's Seafood Bar and Grill" restaurants and "Big Daddy's" retail liquor stores announced results for the 13 weeks ended December 30, 2023. The table below sets forth the results on a comparative basis with the 13 weeks ended December 31, 2022.
(in thousands, except per share amounts) | |||||||||
13 Weeks Ended | 13 Weeks Ended | ||||||||
December 30, 2023 | December 31, 2022 | ||||||||
RESTAURANT FOOD AND BAR SALES | $ | 33,818 | $ | 31,755 | |||||
PACKAGE STORE SALES | 10,602 | 9,403 | |||||||
FRANCHISE RELATED REVENUES | 418 | 459 | |||||||
RENTAL INCOME | 253 | 213 | |||||||
OTHER OPERATING INCOME | 49 | 31 | |||||||
TOTAL REVENUES | $ | 45,140 | $ | 41,861 | |||||
NET INCOME ATTRIBUTABLE TO | |||||||||
FLANIGAN'S ENTERPRISES, INC. | $ | 109 | $ | 624 | |||||
NET INCOME PER COMMON SHARE | |||||||||
BASIC AND DILUTED | $ | 0.06 | $ | 0.34 |
View original content:https://www.prnewswire.com/news-releases/flanigans-reports-earnings-302062221.html
SOURCE FLANIGAN'S ENTERPRISES, INC.
-
5 Undervalued Stocks to Buy to Play a Little Defense
-
Markets Brief: AI Leaders Excel In Earnings Season So Far
-
What History Tells Us About the Fed’s Next Move
-
What’s Happening In the Markets This Week
-
Alphabet’s New Dividend: What Investors Need to Know
-
Going Into Earnings, Is Palantir Stock a Buy, a Sell, or Fairly Valued?
-
Going Into Earnings, Is Eli Lilly Stock a Buy, a Sell, or Fairly Valued?
-
What’s the Difference Between the CPI and PCE Indexes?
-
After Earnings, Is Tesla Stock a Buy, a Sell, or Fairly Valued?
-
After Earnings, Is GE Aerospace Stock a Buy, a Sell, or Fairly Valued?
-
3 Good Stocks to Buy with Your Tax Refund in 2024 (Or with Any Extra Money)
-
SoFi Earnings: Revenue Growth Slows on Lower Loan Growth and Higher Credit Costs
-
Tesla: Full Self-Driving Approval In China Supports Our View for Deliveries Growth In 2024
-
Philips Earnings: Firm Reaches $1.1 Billion Settlement Agreement
-
AbbVie Earnings: Next-Generation Immunology Drugs Help Offset Humira Biosimilar Pressure
-
Exxon Earnings: Ignore Earnings Shortfall as Long-Term Growth and Improvement on Track